Mechoulam, R., Hanuš, L. O., Pertwee, R. & Howlett, A. C. Early phytocannabinoid chemistry to endocannabinoids and beyond. Nat. Rev. Neurosci. 15, 757–764 (2014).
Hua, T. et al. Crystal structure of the human cannabinoid receptor CB1. Cell 167, 750–762 (2016).
Ballesteros, J. A. & Weinstein, H. in Methods in Neurosciences Vol. 25 (ed. Sealfon S. C.) 366–428 (Academic, 1995).
Lemberger, L. Potential therapeutic usefulness of marijuana. Annu. Rev. Pharmacol. Toxicol. 20, 151–172 (1980).
Li, H.-L. An archaeological and historical account of cannabis in China. Econ. Bot. 28, 437–448 (1973).
Makriyannis, A. 2012 Division of Medicinal Chemistry Award Address. Trekking the cannabinoid road: a personal perspective. J. Med. Chem. 57, 3891–3911 (2014).
Shao, Z. et al. High-resolution crystal structure of the human CB1 cannabinoid receptor. Nature 540, 602–606 (2016).
Nikas, S. P. et al. The role of halogen substitution in classical cannabinoids: a CB1 pharmacophore model. AAPS J. 6, e30 (2004).
Nikas, S. P. et al. Novel 1′,1′-chain substituted hexahydrocannabinols: 9β-hydroxy-3-(1-hexyl-cyclobut-1-yl)-hexahydrocannabinol (AM2389) a highly potent cannabinoid receptor 1 (CB1) agonist. J. Med. Chem. 53, 6996–7010 (2010).
Xie, X. Q., Melvin, L. S. & Makriyannis, A. The conformational properties of the highly selective cannabinoid receptor ligand CP-55,940. J. Biol. Chem. 271, 10640–10647 (1996).
Makriyannis, A. & Rapaka, R. S. The medicinal chemistry of cannabinoids: an overview. NIDA Res. Monogr. 79, 204–210 (1987).
Ahn, K. H., Bertalovitz, A. C., Mierke, D. F. & Kendall, D. A. Dual role of the second extracellular loop of the cannabinoid receptor 1: ligand binding and receptor localization. Mol. Pharmacol. 76, 833–842 (2009).
Feigenbaum, J. J. et al. Nonpsychotropic cannabinoid acts as a functional N-methyl-d-aspartate receptor blocker. Proc. Natl Acad. Sci. USA 86, 9584–9587 (1989).
Mechoulam, R. et al. Enantiomeric cannabinoids: stereospecificity of psychotropic activity. Experientia 44, 762–764 (1988).
Hanson, M. A. et al. Crystal structure of a lipid G protein-coupled receptor. Science 335, 851–855 (2012).
Rasmussen, S. G. et al. Crystal structure of the β2 adrenergic receptor–Gs protein complex. Nature 477, 549–555 (2011).
Singh, R. et al. Activation of the cannabinoid CB1 receptor may involve a W6.48/F3.36 rotamer toggle switch. J. Pept. Res. 60, 357–370 (2002).
Tiburu, E. K. et al. Structural biology of human cannabinoid receptor-2 helix 6 in membrane-mimetic environments. Biochem. Biophys. Res. Commun. 384, 243–248 (2009).
Zhang, K. et al. Structure of the human P2Y12 receptor in complex with an antithrombotic drug. Nature 509, 115–118 (2014).
Zhang, J. et al. Agonist-bound structure of the human P2Y12 receptor. Nature 509, 119–122 (2014).
Nikas, S. P. et al. A concise methodology for the synthesis of (−)-Δ9-tetrahydrocannabinol and (−)-Δ9-tetrahydrocannabivarin metabolites and their regiospecifically deuterated analogs. Tetrahedron 63, 8112–8113 (2007).
Kulkarni, S. et al. Novel C-ring-hydroxy-substituted controlled deactivation cannabinergic analogues. J. Med. Chem. 59, 6903–6919 (2016).
D’Antona, A. M., Ahn, K. H. & Kendall, D. A. Mutations of CB1 T210 produce active and inactive receptor forms: correlations with ligand affinity, receptor stability, and cellular localization. Biochemistry 45, 5606–5617 (2006).
Caffrey, M. & Cherezov, V. Crystallizing membrane proteins using lipidic mesophases. Nat. Protocols 4, 706–731 (2009).
Cherezov, V. et al. Rastering strategy for screening and centring of microcrystal samples of human membrane proteins with a sub-10 μm size X-ray synchrotron beam. J. R. Soc. Interface 6, S587–S597 (2009).
Chun, E. et al. Fusion partner toolchest for the stabilization and crystallization of G protein-coupled receptors. Structure 20, 967–976 (2012).
Kabsch, W. XDS. Acta Crystallogr. D 66, 125–132 (2010).
McCoy, A. J. et al. Phaser crystallographic software. J. Appl. Crystallogr. 40, 658–674 (2007).
Adams, P. D. et al. PHENIX: a comprehensive Python-based system for macromolecular structure solution. Acta Crystallogr. D 66, 213–221 (2010).
Smart, O. S. et al. Exploiting structure similarity in refinement: automated NCS and target-structure restraints in BUSTER. Acta Crystallogr. D 68, 368–380 (2012).
Emsley, P., Lohkamp, B., Scott, W. G. & Cowtan, K. Features and development of Coot. Acta Crystallogr. D 66, 486–501 (2010).
Friesner, R. A. et al. Glide: a new approach for rapid, accurate docking and scoring. 1. Method and assessment of docking accuracy. J. Med. Chem. 47, 1739–1749 (2004).
Friesner, R. A. et al. Extra precision glide: docking and scoring incorporating a model of hydrophobic enclosure for protein–ligand complexes. J. Med. Chem. 49, 6177–6196 (2006).
Halgren, T. A. et al. Glide: a new approach for rapid, accurate docking and scoring. 2. Enrichment factors in database screening. J. Med. Chem. 47, 1750–1759 (2004).
Xu, T. et al. Induced-fit docking enables accurate free energy perturbation calculations in homology models. J. Chem. Theory Comput. 18, 5710–5724 (2022).
Abraham, M. J. et al. GROMACS: high performance molecular simulations through multi-level parallelism from laptops to supercomputers. SoftwareX 1–2, 19–25 (2015).
Pettersen, E. F. et al. UCSF Chimera—a visualization system for exploratory research and analysis. J. Comput. Chem. 25, 1605–1612 (2004).
Sousa da Silva, A. W. & Vranken, W. F. ACPYPE—AnteChamber PYthon Parser interfacE. BMC Res. Notes 5, 367 (2012).
Berman, H. M. et al. The Protein Data Bank. Nucl. Acids Res. 28, 235–242 (2000).
Skjærven, L., Yao, X. Q., Scarabelli, G. & Grant, B. J. Integrating protein structural dynamics and evolutionary analysis with Bio3D. BMC Bioinf. 15, 399 (2014).
